AAnaconda Biomed — Series B · €20M
Anaconda Biomed closed a €20M Series B led by Asabys Partners through its Sabadell Asabys Health Innovation Investments fund. Existing investors Ysios Capital, Omega Funds and Innogest joined, along with Sabadell Venture Capital. The money went to clinical studies in Europe and the US, regulatory submissions, product development and scaling up manufacturing. Separately, the company is reported to have taken a €10M loan from the European Investment Bank, which is not counted here.
LeadAsabys Partners
RoundSeries B
Announced4 Dec 2019
CitySant Cugat del Vallès
SectorHealthtech & Bio · Medtech / Neurovascular devices
Source
B
B
